p16INK4 is inactivated by extensive CpG methylation in human hepatocellular carcinoma
- 1 February 1999
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 116 (2), 394-400
- https://doi.org/10.1016/s0016-5085(99)70137-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE).Nucleic Acids Research, 1997
- Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian populationHepatology, 1997
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Inactivation of p16INK4 in hepatocellular carcinomaHepatology, 1996
- Infrequent alterations of thep16INK4A gene in liver cancerInternational Journal of Cancer, 1996
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995
- An efficient method for PCR analysis of mitochondrial DNA from paraffin-embedded archival heart tissue.Genome Research, 1995
- Dependence of transcriptional repression on CpG methylation density.Molecular and Cellular Biology, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancersNature, 1994